Compare GEO & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEO | MMED |
|---|---|---|
| Founded | 1984 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Homebuilding | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.3B |
| IPO Year | 1996 | 2026 |
| Metric | GEO | MMED |
|---|---|---|
| Price | $30.93 | $17.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $39.67 | $22.56 |
| AVG Volume (30 Days) | ★ 1.7M | 1.0M |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 727.27 | N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $2,263,420,000.00 | N/A |
| Revenue This Year | $13.74 | $15.99 |
| Revenue Next Year | $9.99 | $10.00 |
| P/E Ratio | $106.62 | ★ N/A |
| Revenue Growth | ★ 3.85 | N/A |
| 52 Week Low | $12.51 | $10.65 |
| 52 Week High | $32.25 | $17.86 |
| Indicator | GEO | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 68.77 |
| Support Level | $28.74 | $14.70 |
| Resistance Level | $32.25 | N/A |
| Average True Range (ATR) | 0.93 | 0.92 |
| MACD | -0.10 | 0.09 |
| Stochastic Oscillator | 67.52 | 95.75 |
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.